Target intelligence / Profile preview

Synovial sarcoma, X breakpoint 7 (SSX7)

Target
SSX7
Molecular classification
Other, Cancer/testis antigen, Transcriptional regulator (potential)
01

Overview

Synovial sarcoma, X breakpoint 7 (SSX7) is a member of a highly homologous family of SSX proteins located on the X chromosome[4][5]. These proteins may function as transcriptional repressors and are capable of eliciting immune responses in cancer patients, classifying them as cancer/testis antigens[5]. SSX7 itself has not been directly associated with the classic t(X;18) translocation of synovial sarcoma (in contrast to SSX1 and SSX2)[2][5]. The biological functions of SSX7, like other SSX proteins, may involve modulation of gene expression via protein–protein interactions rather than DNA binding[2][5]. While SSX family proteins are of interest in cancer immunotherapy, SSX7 specifically has not been reported as a validated therapeutic target or biomarker at present[5].

Other names
SSX7Protein SSX7synovial sarcoma, X breakpoint 7SSX family member 7
02

Biological functions

Transcriptional repression (potential)Elicitation of immune responses in cancer patients
03

Disease associations

Cancer (primarily studied as part of the SSX gene family’s involvement in synovial sarcoma and as cancer-testis antigens)

Beyond the preview

Go deeper on Synovial sarcoma, X breakpoint 7 (SSX7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synovial sarcoma, X breakpoint 7 (SSX7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call